Results from the PROfound trial showed a statistically significant and clinically meaningful improvement in overall survival

The groups hope to discover cellular receptors or binding proteins of COVID-19

At least 96 mobile testing units should be ready to be deployed by the start of May

The drug’s label now includes a dosing regimen specifically to treat hyperkalaemia in patients with end-stage renal disease […]

Novacyt will supply its COVID-19 test to the DHSC for an initial term of six months

Back in December, Roche unveiled a win for its cocktail of Tecentriq, Cotellic and Zelboraf in patients with […]

Updated Date: Fri, 17 Apr 2020 00:00:00 EDT

Updated Date: Fri, 17 Apr 2020 00:00:00 EDT

Updated Date: Fri, 17 Apr 2020 00:00:00 EDT

Updated Date: Fri, 17 Apr 2020 00:00:00 EDT